752 related articles for article (PubMed ID: 15483083)
1. Adenoviral gene transfer allows Smad-responsive gene promoter analyses and delineation of type I receptor usage of transforming growth factor-beta family ligands in cultured human granulosa luteal cells.
Kaivo-Oja N; Mottershead DG; Mazerbourg S; Myllymaa S; Duprat S; Gilchrist RB; Groome NP; Hsueh AJ; Ritvos O
J Clin Endocrinol Metab; 2005 Jan; 90(1):271-8. PubMed ID: 15483083
[TBL] [Abstract][Full Text] [Related]
2. Growth differentiation factor-9 signaling is mediated by the type I receptor, activin receptor-like kinase 5.
Mazerbourg S; Klein C; Roh J; Kaivo-Oja N; Mottershead DG; Korchynskyi O; Ritvos O; Hsueh AJ
Mol Endocrinol; 2004 Mar; 18(3):653-65. PubMed ID: 14684852
[TBL] [Abstract][Full Text] [Related]
3. Effects of endogenous growth differentiation factor 9 on activin A-induced inhibin B production in human granulosa-lutein cells.
Shi FT; Cheung AP; Huang HF; Leung PC
J Clin Endocrinol Metab; 2009 Dec; 94(12):5108-16. PubMed ID: 19846738
[TBL] [Abstract][Full Text] [Related]
4. Engagement of activin and bone morphogenetic protein signaling pathway Smad proteins in the induction of inhibin B production in ovarian granulosa cells.
Bondestam J; Kaivo-oja N; Kallio J; Groome N; Hydén-Granskog C; Fujii M; Moustakas A; Jalanko A; ten Dijke P; Ritvos O
Mol Cell Endocrinol; 2002 Sep; 195(1-2):79-88. PubMed ID: 12354674
[TBL] [Abstract][Full Text] [Related]
5. Growth differentiation factor-9 induces Smad2 activation and inhibin B production in cultured human granulosa-luteal cells.
Kaivo-Oja N; Bondestam J; Kämäräinen M; Koskimies J; Vitt U; Cranfield M; Vuojolainen K; Kallio JP; Olkkonen VM; Hayashi M; Moustakas A; Groome NP; ten Dijke P; Hsueh AJ; Ritvos O
J Clin Endocrinol Metab; 2003 Feb; 88(2):755-62. PubMed ID: 12574210
[TBL] [Abstract][Full Text] [Related]
6. Activation of the bone morphogenetic protein signaling pathway induces inhibin beta(B)-subunit mRNA and secreted inhibin B levels in cultured human granulosa-luteal cells.
Jaatinen R; Bondestam J; Raivio T; Hildén K; Dunkel L; Groome N; Ritvos O
J Clin Endocrinol Metab; 2002 Mar; 87(3):1254-61. PubMed ID: 11889196
[TBL] [Abstract][Full Text] [Related]
7. Genomic analyses facilitate identification of receptors and signalling pathways for growth differentiation factor 9 and related orphan bone morphogenetic protein/growth differentiation factor ligands.
Mazerbourg S; Hsueh AJ
Hum Reprod Update; 2006; 12(4):373-83. PubMed ID: 16603567
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor-beta- and Activin-Smad signaling pathways are activated at distinct maturation stages of the thymopoeisis.
Rosendahl A; Speletas M; Leandersson K; Ivars F; Sideras P
Int Immunol; 2003 Dec; 15(12):1401-14. PubMed ID: 14645149
[TBL] [Abstract][Full Text] [Related]
9. SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7.
Inman GJ; Nicolás FJ; Callahan JF; Harling JD; Gaster LM; Reith AD; Laping NJ; Hill CS
Mol Pharmacol; 2002 Jul; 62(1):65-74. PubMed ID: 12065756
[TBL] [Abstract][Full Text] [Related]
10. Smad3/AP-1 interactions control transcriptional responses to TGF-beta in a promoter-specific manner.
Verrecchia F; Vindevoghel L; Lechleider RJ; Uitto J; Roberts AB; Mauviel A
Oncogene; 2001 Jun; 20(26):3332-40. PubMed ID: 11423983
[TBL] [Abstract][Full Text] [Related]
11. SB-505124 is a selective inhibitor of transforming growth factor-beta type I receptors ALK4, ALK5, and ALK7.
DaCosta Byfield S; Major C; Laping NJ; Roberts AB
Mol Pharmacol; 2004 Mar; 65(3):744-52. PubMed ID: 14978253
[TBL] [Abstract][Full Text] [Related]
12. Molecular basis of oocyte-paracrine signalling that promotes granulosa cell proliferation.
Gilchrist RB; Ritter LJ; Myllymaa S; Kaivo-Oja N; Dragovic RA; Hickey TE; Ritvos O; Mottershead DG
J Cell Sci; 2006 Sep; 119(Pt 18):3811-21. PubMed ID: 16926195
[TBL] [Abstract][Full Text] [Related]
13. Growth differentiation factor 9 enhances activin a-induced inhibin B production in human granulosa cells.
Shi FT; Cheung AP; Leung PC
Endocrinology; 2009 Aug; 150(8):3540-6. PubMed ID: 19423755
[TBL] [Abstract][Full Text] [Related]
14. Characterization of recombinant human growth differentiation factor-9 signaling in ovarian granulosa cells.
Mottershead DG; Pulkki MM; Muggalla P; Pasternack A; Tolonen M; Myllymaa S; Korchynskyi O; Nishi Y; Yanase T; Lun S; Juengel JL; Laitinen M; Ritvos O
Mol Cell Endocrinol; 2008 Feb; 283(1-2):58-67. PubMed ID: 18162287
[TBL] [Abstract][Full Text] [Related]
15. Dissecting the role of TGF-beta type I receptor/ALK5 in pancreatic ductal adenocarcinoma: Smad activation is crucial for both the tumor suppressive and prometastatic function.
Schniewind B; Groth S; Sebens Müerköster S; Sipos B; Schäfer H; Kalthoff H; Fändrich F; Ungefroren H
Oncogene; 2007 Jul; 26(33):4850-62. PubMed ID: 17297450
[TBL] [Abstract][Full Text] [Related]
16. Growth differentiation factor 9 reverses activin A suppression of steroidogenic acute regulatory protein expression and progesterone production in human granulosa-lutein cells.
Shi FT; Cheung AP; Klausen C; Huang HF; Leung PC
J Clin Endocrinol Metab; 2010 Oct; 95(10):E172-80. PubMed ID: 20660033
[TBL] [Abstract][Full Text] [Related]
17. Expression of transforming growth factor-beta1, activin A, and their receptors in thyroid follicle cells: negative regulation of thyrocyte growth and function.
Franzén A; Piek E; Westermark B; ten Dijke P; Heldin NE
Endocrinology; 1999 Sep; 140(9):4300-10. PubMed ID: 10465304
[TBL] [Abstract][Full Text] [Related]
18. Gene expression profiling demonstrates that TGF-beta1 signals exclusively through receptor complexes involving Alk5 and identifies targets of TGF-beta signaling.
Karlsson G; Liu Y; Larsson J; Goumans MJ; Lee JS; Thorgeirsson SS; Ringnér M; Karlsson S
Physiol Genomics; 2005 May; 21(3):396-403. PubMed ID: 15769904
[TBL] [Abstract][Full Text] [Related]
19. ALK1 opposes ALK5/Smad3 signaling and expression of extracellular matrix components in human chondrocytes.
Finnson KW; Parker WL; ten Dijke P; Thorikay M; Philip A
J Bone Miner Res; 2008 Jun; 23(6):896-906. PubMed ID: 18333754
[TBL] [Abstract][Full Text] [Related]
20. Activin A, B and AB decrease progesterone production by down-regulating StAR in human granulosa cells.
Chang HM; Cheng JC; Huang HF; Shi FT; Leung PC
Mol Cell Endocrinol; 2015 Sep; 412():290-301. PubMed ID: 26001835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
